We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

New Drug Delivery System Targets Diseases at a Genetic Level

News   Dec 06, 2017 | Original story from University of Connecticut

 
New Drug Delivery System Targets Diseases at a Genetic Level

Enzyme-triggered degradation of a drug loaded peptide-crosslinked nucleic acid nanocapsule. First a peptide is crosslinked at the nanoparticle surface (1), then an enzyme recognizes the peptide crosslinker (2), and finally the enzyme cleavage leads to the release of the drug and any intact DNA (3). Credit: (Artwork by Joseph Luciani/UConn)

 
 
Advertisement
 

RELATED ARTICLES

Action! New Tool Generates Movies of How Genomes Change

News

Scientists at the CNAG-CRG and CRG have developed TADdyn, a tool that can generate movies of how genomes change over time.

READ MORE

Researchers Map SARS-CoV-2 Infection in Cells of the Nasal Cavity, Bronchia and Lungs

News

Scientists have characterized the specific ways in which SARS-CoV-2 infects the nasal cavity to a great degree and how it infects and replicates progressively less well in cells lower down the respiratory tract, including the lungs.

READ MORE

Testing for Cancer Risk Whilst at Home

News

A team of researchers has conducted a clinical trial to evaluate different combinations of remote pre- and post-test genetic counseling.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Cell Science Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE